EDIT:NASDAQ
Editas Medicine Inc
1,84 $
arrow_upward
+1,10%(+0,020) 1D
18 նոյ, 09:39:39 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,86 $
High
1,92 $
Low
1,84 $
Mkt. cap
283,98 մլն
Avg. vol.
2,39 մլն
Volume
4,20 հզր
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,86 $
High
1,92 $
Low
1,84 $
Mkt. cap
283,98 մլն
Avg. vol.
2,39 մլն
Volume
4,20 հզր
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 ժամ առաջ
S&P 500 Premarket Movers on Nov. 18
TradingView
·
48 րոպե առաջ
UBS predicts S&P 500 moving up 12% in 2027 but flags major risks around AI
Yahoo Finance
·
24 րոպե առաջ
Investors Love the S&P 500 Index. Here’s Why I Don’t.
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc